{
    "clinical_study": {
        "@rank": "10108", 
        "arm_group": [
            {
                "arm_group_label": "Periodontal treatment", 
                "arm_group_type": "Experimental", 
                "description": "The test group received oral hygiene instructions, supragingival and subgingival scaling and root planning using curettes and an ultrasonic appliance."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "Objective: The aim of this study was to examine the effects of non-surgical periodontal\n      treatment on the hemogram, glycemic and lipid profiles in cardiopathic patients with an\n      indication for surgical revascularization.\n\n      Materials and Methods: Twenty-two patients with chronic periodontitis, over 35 years of age\n      (mean age 59.45 years) randomly assigned into 2 groups were evaluated. Test group (n=11),\n      received periodontal treatment before the surgical procedure, and control group (n=11), did\n      not received periodontal treatment prior to surgery."
        }, 
        "brief_title": "Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles in Patients With Coronariopathies", 
        "condition": [
            "Periodontitis", 
            "Coronariopathy"
        ], 
        "condition_browse": {
            "mesh_term": "Periodontitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Undergoing cardiovascular treatment;\n\n          -  Eight viable teeth in the oral cavity;\n\n          -  Four periodontal sites with periodontal probing depths \u22655mm in different teeth.\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "22", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02150005", 
            "org_study_id": "UVA71/06"
        }, 
        "intervention": {
            "arm_group_label": "Periodontal treatment", 
            "intervention_name": "Periodontal treatment", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "periodontal diseases", 
            "cardiovascular diseases", 
            "periodontitis treatment"
        ], 
        "lastchanged_date": "May 25, 2014", 
        "number_of_arms": "2", 
        "official_title": "Effects of Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles of Patients With an Indication for Surgical Coronary Revascularization", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Reduction of 11.4% in probing depth in sites with Periodontal Probing Depth>3mm", 
                "measure": "Reduction in probing depth in sites with PPD>3mm", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after the initial exam"
            }, 
            {
                "description": "Reduction of 6.3% in probing depth in sites with Periodontal Probing Depth>5mm", 
                "measure": "Reduction in probing depth in sites with PPD>5mm", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after the initial exam"
            }, 
            {
                "description": "Reduction of 4.6% in probing depth in sites with Clinical Attachment Level >3mm.", 
                "measure": "Reduction in probing depth in sites with CAL>3mm", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after the initial exam"
            }, 
            {
                "description": "Reduction of 3.6% in probing depth in sites with Clinical Attachment Level >5mm.", 
                "measure": "Reduction in probing depth in sites with CAL >5mm", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after the initial exam"
            }, 
            {
                "description": "Non-significant reduction of leukocyte count in the test group. Mean difference of 74.6 m/mcL.", 
                "measure": "Leukocyte count", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after the initial exam"
            }, 
            {
                "description": "Glucose showed a non-significant increase in the test group. Mean difference of 24.2 mg/dL.", 
                "measure": "Glucose", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after the initial exam"
            }, 
            {
                "description": "Hemocyte presented a non-significant reduction in the test group. Mean difference 0.39 m/mcL", 
                "measure": "Hemocyte", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after initial exam"
            }, 
            {
                "description": "Non-significant reduction in test group. Mean difference of 0.2 g/dL", 
                "measure": "Hemoglobin", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after initial exam"
            }, 
            {
                "description": "Significant reduction in the test group. Mean reduction of 27.4 mg/dL.", 
                "measure": "Total Cholesterol", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after initial exam"
            }, 
            {
                "description": "Significant reduction in test group. Mean difference of 8.2 mg/dL.", 
                "measure": "High density lipid", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after initial exam"
            }, 
            {
                "description": "Non-significant reduction in test group. Mean difference of 8.9 mg/dL.", 
                "measure": "Low density lipid", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days after initial exam"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02150005"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rio de Janeiro State University", 
            "investigator_full_name": "Walmir J\u00fanio de Pinho Reis Rodrigues", 
            "investigator_title": "Researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Universidade Veiga de Almeida", 
        "sponsors": {
            "collaborator": {
                "agency": "Rio de Janeiro State Research Supporting Foundation (FAPERJ)", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Universidade Veiga de Almeida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}